Tag Archives: BIO Events

What’s In Store for Biotechs at this Year’s CEO & Investor Conference

CEO2014_blog copy

In just a few weeks, industry leaders will gather in New York for one of BIO’s largest and most successful events, the 16th Annual BIO CEO & Investor Conference. As we’ve seen at JPMorgan, the extraordinary performance of biotech equities for the past several years has generated a great deal of interest among investors to work with biotech companies to foster innovation in the coming year. This year’s event is shaping up to be even Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Bioscience’s Bright Spots

2014_BIO

According to Business Xpansion Journal, biotech is still big business and partnerships lead to profit. And BIO agrees. “In the past several years, it has become more important than ever for those in our industry to form partnerships and collaborations,” says Fritz Bittenbender, executive vice president, external affairs, BIO. “Big pharma, small biotechs, universities, investors, patient groups, the NIH – everyone is recognizing that success is only achieved by working with others. One place we’ve seen this Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Emerging-Companies115x76

Innovative biotech companies at all stages of the development process are working toward next generation technologies to heal, fuel, and feed the world. In an effort to highlight promising policy legislation and its impact on the biotech sector, BIO has authored the following white paper: The Future Policy Landscape for Emerging Biotechnology Companies. Many research-intensive companies rely on private investment to support their groundbreaking R&D. Therefore, favorable legislation such as the JOBS Act is essential Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO 2013 Pacific Rim Summit Ends with a Look at Natural Gas

Pac_Rim115x75

This year marked the first time in the event’s eight year history that it was held in California. With 400 attendees present, BIO’s 2013 Pacific Rim Summit had a record number of exhibitors, poster presenters, and media present. BIO concluded its summit with a robust plenary titled, The Golden Age of Gas, moderated by Jonathan Burbaum, Program Director at ARPA-E, panelists consisted of the Laurel Harmon, VP of Government Relations, Lanzatech, Alan Shaw, Chairman of the Board, Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , ,

What’s Behind the Biotech IPO Boom?

BIOtech-stocks

Everyone knows that it’s been a knock-out year for the biotech sector in the public markets, which includes a large and well-performing IPO class. So far in 2013, 39 US-based companies have gone public, five European-based companies, and one Canadian company. Of these 45 IPOs, 42 companies have gone public on US stock exchanges. That’s over double the amount we saw in 2012. This year’s IPOs have also been successful at raising the amount of money Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,